Skip to main content
All lobbying filings

HB STRATEGIES

Lobbying for BAYER U.S. LLC · Pharmaceutical and life sciences company

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $120,000.00 income · posted Oct 17, 2025

Official filing document

 Lobbying activity 3
Health Issues

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Agriculture

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Pharmacy

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem